Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Epigenetic regulation of glucose transporters in non-small cell lung cancer.

O'Byrne KJ, Baird AM, Kilmartin L, Leonard J, Sacevich C, Gray SG.

Cancers (Basel). 2011 Mar 25;3(2):1550-65. doi: 10.3390/cancers3021550.

2.

Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?

Choi WH, Yoo IeR, O JH, Kim TJ, Lee KY, Kim YK.

Technol Health Care. 2015;23 Suppl 2:S311-8. doi: 10.3233/THC-150967.

PMID:
26410497
3.

Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.

Reske SN, Grillenberger KG, Glatting G, Port M, Hildebrandt M, Gansauge F, Beger HG.

J Nucl Med. 1997 Sep;38(9):1344-8.

4.

Correlation of Glut-1 glucose transporter expression with.

Higashi K, Ueda Y, Sakurai A, Wang XM, Xu L, Murakami M, Seki H, Oguchi M, Taki S, Nambu Y, Tonami H, Katsuda S, Yamamoto I.

Eur J Nucl Med. 2000 Dec;27(12):1778-85.

PMID:
11189940
5.

18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.

Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A.

Eur J Cardiothorac Surg. 2013 Aug;44(2):e105-12. doi: 10.1093/ejcts/ezt263. Epub 2013 May 14.

PMID:
23674658
6.

Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.

Maher JC, Savaraj N, Priebe W, Liu H, Lampidis TJ.

Pancreas. 2005 Mar;30(2):e34-9.

PMID:
15714127
7.

Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.

Paudyal B, Paudyal P, Oriuchi N, Tsushima Y, Nakajima T, Endo K.

Int J Oncol. 2008 Nov;33(5):1047-54.

PMID:
18949368
8.

2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.

Ong LC, Jin Y, Song IC, Yu S, Zhang K, Chow PK.

Acta Radiol. 2008 Dec;49(10):1145-53. doi: 10.1080/02841850802482486.

PMID:
18979289
9.

Biological correlates of FDG uptake in non-small cell lung cancer.

de Geus-Oei LF, van Krieken JH, Aliredjo RP, Krabbe PF, Frielink C, Verhagen AF, Boerman OC, Oyen WJ.

Lung Cancer. 2007 Jan;55(1):79-87. Epub 2006 Oct 13.

PMID:
17046099
10.

Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.

Brown RS, Leung JY, Kison PV, Zasadny KR, Flint A, Wahl RL.

J Nucl Med. 1999 Apr;40(4):556-65.

11.

Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading.

Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, Nakada K, Hosokawa M, Kohanawa M, Tamaki N.

Nucl Med Commun. 2002 Jun;23(6):545-50.

PMID:
12029209
12.

Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.

Marom EM, Aloia TA, Moore MB, Hara M, Herndon JE 2nd, Harpole DH Jr, Goodman PC, Patz EF Jr.

Lung Cancer. 2001 Aug-Sep;33(2-3):99-107.

PMID:
11551404
13.
14.

Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.

Higashi T, Tamaki N, Honda T, Torizuka T, Kimura T, Inokuma T, Ohshio G, Hosotani R, Imamura M, Konishi J.

J Nucl Med. 1997 Sep;38(9):1337-44.

15.

Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice.

Chung JK, Lee YJ, Kim C, Choi SR, Kim M, Lee K, Jeong JM, Lee DS, Jang JJ, Lee MC.

J Nucl Med. 1999 Feb;40(2):339-46.

17.
18.
19.

Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.

Busk M, Horsman MR, Kristjansen PE, van der Kogel AJ, Bussink J, Overgaard J.

Int J Cancer. 2008 Jun 15;122(12):2726-34. doi: 10.1002/ijc.23449.

20.

Supplemental Content

Support Center